title: Effects of dauricine and tetrandrine on [3H] WEB 2086 specific binding to bovine anterior cerebral arterial smooth muscle cells in vitro.
abstract: By using [3H] WEB 2086, a PAF antagonist, specific binding sites of PAF on bovine anterior cerebral arterial smooth muscle cells was identified. Two populations of binding sites with different dissociation constants on the cells were found. The Kd-1 = 22.8 +/- 5.0 nmol.L-1, Kd-2 = 186 +/- 20.5 nmol.L-1 at 25 C. The total number of binding sites were Bmax-1 = 2.1 +/- 0.3 pmol/10(6) cells and Bmax-2 = 12.1 +/- 1.5 pmol/10(6) cells. Dauricine and tetrandrine, two active compounds with similar chemical structure extracted from traditional Chinese herbs, were found to inhibit [3H] WEB 2086 specific binding significantly in culture cells.
authors.affiliation: Department of Pharmacology, School of Pharmacy, Second Military Medical University, Shanghai.
authors.forename: G Q
authors.initials: GQ
authors.lastname: Zeng
authors.forename: D W
authors.initials: DW
authors.lastname: Ju
authors.forename: D X
authors.initials: DX
authors.lastname: Sun
authors.forename: T G
authors.initials: TG
authors.lastname: Huang
authors.forename: Y C
authors.initials: YC
authors.lastname: Rui
mesh_terms: D000470:Alkaloids / Q000494:pharmacology*; D000818:Animals; D001381:Azepines / Q000378:metabolism*; D044182:Benzylisoquinolines; D001665:Binding Sites / Q000187:drug effects; D002417:Cattle; D002536:Cerebral Arteries / Q000378:metabolism; D007546:Isoquinolines / Q000494:pharmacology*; D009131:Muscle, Smooth, Vascular / Q000166:cytology / Q000378:metabolism*; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors / Q000378:metabolism; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D010980:Platelet Membrane Glycoproteins / Q000187:drug effects*; D011956:Receptors, Cell Surface; D043562:Receptors, G-Protein-Coupled; D044005:Tetrahydroisoquinolines; D014230:Triazoles / Q000378:metabolism*
chemical_list: D000470:Alkaloids; D001381:Azepines; D044182:Benzylisoquinolines; D007546:Isoquinolines; D010972:Platelet Activating Factor; D010975:Platelet Aggregation Inhibitors; D010980:Platelet Membrane Glycoproteins; D011956:Receptors, Cell Surface; D043562:Receptors, G-Protein-Coupled; D044005:Tetrahydroisoquinolines; D014230:Triazoles; C039351:platelet activating factor receptor; C052518:WEB 2086; C009438:tetrandrine; C035934:dauricine